Home › Hidradenitis Suppurativa
Pag-aaral pangklinika para sa Hidradenitis Suppurativa na nagre-recruit sa U.S.
30 pag-aaral para sa Hidradenitis Suppurativa ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- Boston, MA9 pag-aaral
- Birmingham, AL7 pag-aaral
- New York City, NY7 pag-aaral
- Miami, FL6 pag-aaral
- Tampa, FL6 pag-aaral
- Durham, NC6 pag-aaral
- Bowling Green, KY5 pag-aaral
- Phoenix, AZ5 pag-aaral
- The Bronx, NY5 pag-aaral
- Baton Rouge, LA5 pag-aaral
- Dallas, TX4 pag-aaral
- Evanston, IL4 pag-aaral
- St. Louis, MO4 pag-aaral
- Minneapolis, MN4 pag-aaral
- Santa Clarita, CA4 pag-aaral
- Detroit, MI3 pag-aaral
- Houston, TX3 pag-aaral
- Hartford, CT3 pag-aaral
- Baltimore, MD3 pag-aaral
- Troy, MI3 pag-aaral
- Sandy Springs, GA3 pag-aaral
- Evansville, IN3 pag-aaral
- Oklahoma City, OK3 pag-aaral
- Kendall, FL3 pag-aaral
- Atlanta, GA3 pag-aaral
- Indianapolis, IN3 pag-aaral
- Cleveland, OH3 pag-aaral
- Los Angeles, CA3 pag-aaral
- San Antonio, TX3 pag-aaral
- New Orleans, LA3 pag-aaral
- Chicago, IL3 pag-aaral
- West Lafayette, IN3 pag-aaral
- Philadelphia, PA3 pag-aaral
- Norfolk, VA3 pag-aaral
- San Francisco, CA3 pag-aaral
- Scottsdale, AZ3 pag-aaral
Ayos sa estado
- Alabama7 pag-aaral
- Arizona6 pag-aaral
- California13 pag-aaral
- Connecticut3 pag-aaral
- Florida10 pag-aaral
- Georgia8 pag-aaral
- Illinois6 pag-aaral
- Indiana7 pag-aaral
- Kentucky7 pag-aaral
- Louisiana6 pag-aaral
- Maryland3 pag-aaral
- Massachusetts10 pag-aaral
- Michigan7 pag-aaral
- Minnesota4 pag-aaral
- Missouri6 pag-aaral
- New York10 pag-aaral
- North Carolina7 pag-aaral
- Ohio5 pag-aaral
- Oklahoma4 pag-aaral
- Pennsylvania6 pag-aaral
- South Carolina3 pag-aaral
- Tennessee3 pag-aaral
- Texas9 pag-aaral
- Utah3 pag-aaral
- Virginia4 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
Nagre-recruitPhase 2
Edad 12 hanggang 17 · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT07213973Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT06855498A Study to Explore the Tissue Level Effects of Remibrutinib in Adults With Moderate to Severe HS
Nagre-recruitPhase 1
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT07855276Efficacy and Safety of Olatorepatide Versus Placebo in Adults With Moderate to Severe Hidradenitis Suppurativa Living With Overweight or Obesity
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT07830329An Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HS
Nagre-recruitPhase 3
Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT07665437ORKA-002 Versus Placebo in Participants With Moderate-to-Severe Hidradenitis Suppurativa
Nagre-recruitPhase 2
Edad 18 hanggang 79 · Lahat ng kasarian · Na-update Okt 29, 2026 · NCT07783542A Study of SPY072 in Adults With Moderate to Severe Hidradenitis Suppurativa (The SKYLIGHT Trial)
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Okt 19, 2026 · NCT07766005A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 16, 2026 · NCT07225569Safety and Efficacy of Soquelitinib in Adults With Hidradenitis Suppurativa
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 15, 2026 · NCT07828860Brivekimig for the Treatment of Moderate to Severe Hidradenitis Suppurativa
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 14, 2026 · NCT07170917Safety and Efficacy of Roflumilast Foam 0.3% in Adolescent and Adult Subjects With Hidradenitis Suppurativa
Nagre-recruitPhase 2
Edad 12 pataas · Lahat ng kasarian · Na-update Okt 13, 2026 · NCT07689188Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa
Nagre-recruitPhase 1
Edad 12 hanggang 75 · Lahat ng kasarian · Na-update Okt 9, 2026 · NCT07049575Regulation of Inflammatory Genes in Hidradenitis Suppurativa
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 89 · Lahat ng kasarian · Na-update Set 21, 2026 · NCT05507125A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)
Nagre-recruitPhase 1
Edad 18 pataas · Kababaihan · Na-update Set 18, 2026 · NCT06888193Targeting Nociceptors in Hidradenitis Suppurativa
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 10, 2026 · NCT05403710Capsule Microbiota Transplant Therapy for Hidradenitis Suppurativa
Nagre-recruitMaagang Phase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 3, 2026 · NCT06058520Evaluate the Safety and Efficacy of Subcutaneous Siplizumab in the Treatment of Hidradenitis Suppurativa.
Nagre-recruitMaagang Phase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 1, 2026 · NCT06326476A Study to Assess NAV-240 in Adult Participants With Hidradenitis Suppurativa
Nagre-recruitPhase 2
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Hul 22, 2026 · NCT07384975Myriad™ Augmented Soft Tissue Reconstruction Registry
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 15, 2026 · NCT05243966The Safety and Efficacy of Roflumilast Foam in HS
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 9, 2026 · NCT07263230Pelashield™ PainGuard™ vs Restrata® in HS Surgery
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update May 22, 2026 · NCT07316192Radiotherapy for Refractory Hidradenitis Suppurativa
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update May 15, 2026 · NCT07414550Clinical and Biological Characteristics of Hidradenitis Suppurativa
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 13 pataas · Lahat ng kasarian · Na-update May 4, 2026 · NCT03967600Hidradenitis Suppurativa Prospective Observational Registry and Biospecimen Repository
Nagre-recruitObservasyonal na pag-aaral
Edad 10 pataas · Lahat ng kasarian · Na-update Abr 29, 2026 · NCT04115566A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 71 · Lahat ng kasarian · Na-update Abr 16, 2026 · NCT07123038Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.